Disease Markers

Find the Essence through the Phenomena: Cardiovascular Diseases and Biomarkers


Status
Published

Lead Editor

1Augusta University, Augusta, USA

2Medical University of Lodz, Lodz, Poland

3Wayne State University, Michigan, USA

4Moscow Institute of Physics and Technology, Moscow, Russia


Find the Essence through the Phenomena: Cardiovascular Diseases and Biomarkers

Description

Biomarkers are often measured and evaluated to determine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.

Our current issue focuses on the new advances in cardiovascular diseases and biomarkers. The goal of this special issue is to summarize new biomarkers in risk prediction, screening, diagnosis, progression, and prognosis of cardiovascular diseases; measurement relevance of biomarkers addressing specificity, sensitivity, and biological variation of these biomarkers; the role of biomarkers in evaluation and guidance of drug therapies. This issue will let our readers better understand the importance of biomarkers in cardiovascular diseases.

Potential topics include but are not limited to the following:

  • Advances in serum biomarkers and cardiovascular diseases
  • Advances in imagine biomarkers and cardiovascular diseases
  • Advances in anatomical biomarkers and cardiovascular diseases
  • Advances in therapeutic biomarkers and cardiovascular diseases
  • Metrology and biomarkers in cardiovascular diseases
  • Biomarkers in evaluation of cardiovascular toxicity from chemo- and radiotherapy

Articles

  • Special Issue
  • - Volume 2020
  • - Article ID 8833885
  • - Research Article

Clinicopathological and Prognostic Roles of STAT3 and Its Phosphorylation in Glioma

Bo Liang | Shuang-Yang Li | ... | Ning Gu
  • Special Issue
  • - Volume 2020
  • - Article ID 8818358
  • - Research Article

Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients

Yang Ling | Shengxing Tang | ... | Cong Fu
  • Special Issue
  • - Volume 2020
  • - Article ID 8815270
  • - Research Article

Association of the Expression Level of miR-16 with Prognosis of Solid Cancer Patients: A Meta-Analysis and Bioinformatic Analysis

Wanting Zhang | Feixiang Zhou | ... | Ding Ye
  • Special Issue
  • - Volume 2020
  • - Article ID 8521899
  • - Research Article

Long Noncoding RNAs CARMN, LUCAT1, SMILR, and MALAT1 in Thoracic Aortic Aneurysm: Validation of Biomarkers in Clinical Samples

Vaiva Patamsytė | Giedrius Žukovas | ... | Vaiva Lesauskaitė
  • Special Issue
  • - Volume 2018
  • - Article ID 1929106
  • - Editorial

Find the Essence through the Phenomena: Cardiovascular Diseases and Biomarkers

Zhongjie Shi | Agata M. Bielecka-Dabrowa | ... | Shipeng Wei
  • Special Issue
  • - Volume 2018
  • - Article ID 5285392
  • - Research Article

Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis

Agata Salska | Michał Dziuba | ... | Marzenna Zielinska
  • Special Issue
  • - Volume 2018
  • - Article ID 9749457
  • - Research Article

Mitochondrial Genome Mutations Associated with Myocardial Infarction

Margarita A. Sazonova | Anastasia I. Ryzhkova | ... | Alexander N. Orekhov
  • Special Issue
  • - Volume 2018
  • - Article ID 5812802
  • - Research Article

A Novel Polymorphism in the Promoter of the CYP4A11 Gene Is Associated with Susceptibility to Coronary Artery Disease

Svetlana Sirotina | Irina Ponomarenko | ... | Alexey Polonikov
  • Special Issue
  • - Volume 2018
  • - Article ID 5287573
  • - Research Article

The Role of Parathyroid Hormone and Vitamin D Serum Concentrations in Patients with Cardiovascular Diseases

Agnieszka Kolaszko | Ewa Nowalany-Kozielska | ... | Grzegorz Kubiak
  • Special Issue
  • - Volume 2017
  • - Article ID 8458492
  • - Research Article

Prognostic Association of Circulating Neutrophil Count with No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction following Successful Primary Percutaneous Intervention

Jinfan Tian | Yue Liu | ... | Shuzheng Lyu
Disease Markers
 Journal metrics
Acceptance rate34%
Submission to final decision88 days
Acceptance to publication43 days
CiteScore4.100
Impact Factor3.434
 Submit

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.